General Information of Drug (ID: DMOGDCQ)

Drug Name
Ab-01 Drug Info
Synonyms Ab-02; IL-21 receptor-targeted human monoclonal antibodies (inflammation); Anti-IL-21R mAb (inflammation), Pfizer; IL-21 receptor-targeted human monoclonal antibodies (inflammation), Pfizer
Indication
Disease Entry ICD 11 Status REF
Inflammation 1A00-CA43.1 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMOGDCQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATR-107 DMBCATZ Crohn disease DD70 Phase 1 [3]
AMG 256 DMXYCZV Solid tumour/cancer 2A00-2F9Z Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin 21 receptor (IL21R) TTZO9B0 IL21R_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT00447837) Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis. U.S. National Institutes of Health.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2304).
3 Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol. 2014 Jan;54(1):14-22.
4 Clinical pipeline report, company report or official report of Amgen.